Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G L Deliliers
Low-Dose Subcutaneous Alemtuzumab in Refractory Chronic Lymphocytic Leukaemia (CLL): Results of a Prospective, Single-Arm Multicentre Study
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Treatment-Related Mortality and Graft-Versus-Leukemia Activity After Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Using Intensity-Reduced Conditioning
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
The Use of Low-Dose Alemtuzumab in Pretreated B-Cell Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Cost-Effectiveness of Ibrutinib in Patients With Relapsed or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Filgrastim and Alemtuzumab (Campath-1h) for Refractory Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Relationship Between Comorbidities at Diagnosis, Survival and Ultimate Cause of Death in Patients With Chronic Lymphocytic Leukaemia (CLL): A Prospective Cohort Study
British Journal of Haematology
Hematology
Analysis of Treatment Options for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Chronic Lymphocytic Leukaemia
Nature Reviews Disease Primers
Medicine
A Phase II Trial of Eltrombopag for Patients With Chronic Lymphocytic Leukaemia (CLL) and Thrombocytopenia
British Journal of Haematology
Hematology
Comparative Analysis of Targeted Novel Therapies in Relapsed, Refractory Chronic Lymphocytic Leukaemia
Haematologica
Hematology
